Ursodeoxycholic acid therapy in primary biliary cirrhosis

M. Podda, A. Crosignani, P. M. Battezzati, M. Quagliuolo, C. Valsania, P. Invernizzi, M. Zuin

Research output: Contribution to journalArticlepeer-review


A review is made of the literature regarding the present status of ursodeoxycholic acid in the treatment of primary biliary cirrhosis, focusing on the difficulties encountered in establishing the efficacy of this and any other therapy in the management of the disease. It is concluded that further studies or, at least, an updated meta-analysis including the final data emerging from the multicentre, long-term, randomised, double-blind, controlled trials currently under way are needed to establish the clinical importance of ursodeoxycholic acid as a therapeutic agent in primary biliary cirrhosis.

Original languageEnglish
Pages (from-to)114-117
Number of pages4
JournalItalian Journal of Gastroenterology
Issue number2
Publication statusPublished - 1996


  • Cholestasis
  • Primary biliary cirrhosis
  • Ursodeoxycholic acid

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Ursodeoxycholic acid therapy in primary biliary cirrhosis'. Together they form a unique fingerprint.

Cite this